Involvement of eosinophils in the anti-tumor response
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eosinophils have long been associated with allergy and parasitic infections. Today, they are considered as multifunctional leukocytes, which participate both in innate and adaptive immune response though the expression of various receptors and mediators. Although the tumor-associated eosinophilia is observed for a long time in many hematological and solid malignancies, with a generally good prognosis value, there is a lack of knowledge on the different mechanisms involved in this phenomenon. Moreover, the recent discovery in human eosinophils of different receptors and mediators, shared with lymphocytes and involved in anti-tumor defense, suggests that eosinophils can play a role in anti-tumoral immunity. We review in the present paper the current knowledge on epidemiology, recruitment, and mechanisms involved in the response of eosinophils toward tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Considering that eosinophils can have a role in the response against cancer,17–20 an elevated AEC might be a marker of effectiveness in some patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Eosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
Mechanisms of eosinophil-associated inflammation
Gleich, G. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105712 · Cited by 785
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
High-affinity IgE receptor on eosinophils is involved in defence against parasites
Soussi Gounni, A., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J.-P., & Capron, M. (1994) · Nature · doi:10.1038/367183a0 · Cited by 517
Self-citationYang, D., Chen, Q., Su, S. B., Zhang, P., Kurosaka, K., Caspi, R. R., Michalek, S. M., Rosenberg, H. F., Zhang, N., & Oppenheim, J. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20062027 · Cited by 352
Eosinophils: multifaceted biological properties and roles in health and disease
Kita, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01026.x · Cited by 336
Eosinophils in health and disease: the LIAR hypothesis
Lee, J. J., Jacobsen, E. A., McGarry, M. P., Schleimer, R. P., & Lee, N. A. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03484.x · Cited by 334
Ikutani, M., Yanagibashi, T., Ogasawara, M., Tsuneyama, K., Yamamoto, S., Hattori, Y., Kouro, T., Itakura, A., Nagai, Y., Takaki, S., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101270 · Cited by 314
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., & Parish, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021683 · Cited by 256
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity
Davoine, F., & Lacy, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00570 · Cited by 353
A new dawn for eosinophils in the tumour microenvironment
Grisaru-Tal, S., Itan, M., Klion, A. D., & Munitz, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0283-9 · Cited by 302
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Hollande, C., Boussier, J., Ziai, J., Nozawa, T., Bondet, V., Phung, W., Lu, B., Duffy, D., Paradis, V., Mallet, V., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0321-5 · Cited by 234
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 225
Lucarini, V., Ziccheddu, G., Macchia, I., La Sorsa, V., Peschiaroli, F., Buccione, C., Sistigu, A., Sanchez, M., Andreone, S., D'Urso, M. T., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1317420 · Cited by 199
Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer
Reichman, H., Itan, M., Rozenberg, P., Yarmolovski, T., Brazowski, E., Varol, C., Gluck, N., Shapira, S., Arber, N., Qimron, U., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0494 · Cited by 176
Role of LFA-1 and ICAM-1 in Cancer
Reina, M., & Espel, E. (2017) · Cancers · doi:10.3390/cancers9110153 · Cited by 162
Moreira, A., Leisgang, W., Schuler, G., & Heinzerling, L. (2017) · Immunotherapy · doi:10.2217/imt-2016-0138 · Cited by 147
Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
Galdiero, M. R., Varricchi, G., Seaf, M., Marone, G., Levi-Schaffer, F., & Marone, G. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00103 · Cited by 121
Galectin-9 in tumor biology: A jack of multiple trades
Heusschen, R., Griffioen, A. W., & Thijssen, V. L. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.006 · Cited by 131
Mast cells, basophils and eosinophils: From allergy to cancer
Rigoni, A., Colombo, M. P., & Pucillo, C. E. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.001 · Cited by 119
Domagala-Kulawik, J. J. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.01.11 · Cited by 118
Loktionov, A. S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i27.3503 · Cited by 118
Emerging Roles for Eosinophils in the Tumor Microenvironment
Reichman, H., Karo-Atar, D., & Munitz, A. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.002 · Cited by 116
A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System
Long, H., Liao, W., Wang, L., & Lu, Q. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445215 · Cited by 109
Prizment, A. E., Vierkant, R. A., Smyrk, T. C., Tillmans, L. S., Lee, J. J., Sriramarao, P., Nelson, H. H., Lynch, C. F., Thibodeau, S. N., Church, T. R., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.42 · Cited by 108
AllergoOncology – the impact of allergy in oncology: EAACI position paper
Jensen‐Jarolim, E., Bax, H. J., Bianchini, R., Capron, M., Corrigan, C., Castells, M., Dombrowicz, D., Daniels‐Wells, T. R., Fazekas, J., Fiebiger, E., et al. (2017) · Allergy · doi:10.1111/all.13119 · Cited by 96
Self-citationAndreone, S., Spadaro, F., Buccione, C., Mancini, J., Tinari, A., Sestili, P., Gambardella, A. R., Lucarini, V., Ziccheddu, G., Parolini, I., et al. (2019) · Cancers · doi:10.3390/cancers11111664 · Cited by 102
Gatault, S., Delbeke, M., Driss, V., Sarazin, A., Dendooven, A., Kahn, J., Lefèvre, G., & Capron, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402914 · Cited by 88
Self-citationHistamine in cancer immunology and immunotherapy. Current status and new perspectives
Sarasola, M. D. L. P., Delgado, M. A. T., Nicoud, M. B., & Medina, V. A. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.778 · Cited by 86
Association between Allergies and Risk of Pancreatic Cancer
Cotterchio, M., Lowcock, E. C., Hudson, T. J., Greenwood, C. M. T., & Gallinger, S. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0965 · Cited by 76
Kim, Y., Kang, J., Kang, J., Kwon, E. J., Ha, M., Kim, Y. K., Lee, H., Rhee, J., & Kim, Y. H. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1904573 · Cited by 75
Scanvion, Q., Béné, J., Gautier, S., Grandvuillemin, A., Le Beller, C., Chenaf, C., Etienne, N., Brousseau, S., Cortot, A. B., Mortier, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1722022 · Cited by 59
IgE immunotherapy: A novel concept with promise for the treatment of cancer
Josephs, D. H., Spicer, J. F., Karagiannis, P., Gould, H. J., & Karagiannis, S. N. (2014) · mAbs · doi:10.4161/mabs.27029 · Cited by 58
Fattahi, Z., Khosroushahi, A. Y., & Hasanzadeh, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110850 · Cited by 58
Hu, G., Wang, S., Zhong, K., Xu, F., Huang, L., Chen, W., & Cheng, P. (2020) · BMC Cancer · doi:10.1186/s12885-020-06966-3 · Cited by 57
Bolus, W. R., Gutierrez, D. A., Kennedy, A. J., Anderson‐Baucum, E. K., & Hasty, A. H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0115-018r · Cited by 48
Holub, K., & Biete, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-5131-x · Cited by 46
Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond
Folci, M., Ramponi, G., Arcari, I., Zumbo, A., & Brunetta, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_640 · Cited by 46
Myeloid Cells as Targets for Therapy in Solid Tumors
Cotechini, T., Medler, T. R., & Coussens, L. M. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000132 · Cited by 39
Pesce, S., Thorén, F. B., Cantoni, C., Prato, C., Moretta, L., Moretta, A., & Marcenaro, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00510 · Cited by 43
Jacobs, E. J., Gapstur, S. M., Newton, C. C., Turner, M. C., & Campbell, P. T. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1229 · Cited by 42
Shen, Z.-J., Hu, J., Esnault, S. J., Dozmorov, I. M., & Malter, J. S. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.012 · Cited by 40
IgE Immunotherapy Against Cancer
Leoh, L. S., Daniels‐Wells, T. R., & Penichet, M. L. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-13725-4_6 · Cited by 39
Cicchelero, L., Denies, S., Haers, H., Vanderperren, K., Stock, E., Brantegem, L. V., de Rooster, H., & Sanders, N. N. (2016) · Veterinary and Comparative Oncology · doi:10.1111/vco.12255 · Cited by 38
IgE‐based immunotherapy of cancer: challenges and chances
Singer, J., & Jensen‐Jarolim, E. (2013) · Allergy · doi:10.1111/all.12276 · Cited by 35
Zhao, Q., Chen, Y., Du, S., Yang, X., Chen, Y., Ji, Y., & Zeng, Z. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1834792 · Cited by 35
Onesti, C. E., Josse, C., Boulet, D., Thiry, J., Beaumecker, B., Bours, V., & Jérusalem, G. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1761176 · Cited by 34
Nishina, S., & Hino, K. (2022) · Cancers · doi:10.3390/cancers14020454 · Cited by 34
Caliman, E., Fancelli, S., Ottanelli, C., Mazzoni, F., Paglialunga, L., Lavacchi, D., Michelet, M. R. G., Giommoni, E., Napolitano, B., Scolari, F., et al. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100603 · Cited by 34
Alaeddine, M., Prat, M., Poinsot, V., Gouazé‐Andersson, V., Authier, H., Meunier, É., Lefèvre, L., Alric, C., Dardenne, C., Bernad, J., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0213 · Cited by 34
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
Artham, S., Juras, P. K., Goyal, A., Chakraborty, P., Byemerwa, J. K., Liu, S., Wardell, S. E., Chakraborty, B., Crowder, D., Lim, F., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp2442 · Cited by 33
Eosinophilia in cancer and its regulation by sex hormones
Artham, S., Chang, C., & McDonnell, D. P. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.11.002 · Cited by 33
The nascent field of AllergoOncology
Jensen‐Jarolim, E., & Pawelec, G. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1315-4 · Cited by 33
Takeuchi, E., Kondo, K., Okano, Y., Ichihara, S., Kunishige, M., Kadota, N., Machida, H., Hatakeyama, N., Naruse, K., Ogino, H., et al. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15100 · Cited by 31
Immunity and Breast Cancer: Focus on Eosinophils
Poncin, A., Onesti, C. E., Josse, C., Boulet, D., Thiry, J., Bours, V., & Jérusalem, G. (2021) · Biomedicines · doi:10.3390/biomedicines9091087 · Cited by 30
Saraiva, A. L., & Carneiro, F. (2018) · Acta Médica Portuguesa · doi:10.20344/amp.10112 · Cited by 30
Onesti, C. E., Josse, C., Poncin, A., Frères, P., Poulet, C., Bours, V., & Jérusalem, G. (2018) · Oncotarget · doi:10.18632/oncotarget.26120 · Cited by 30
Hude, I., Sasse, S., Bröckelmann, P. J., von Tresckow, B., Momotow, J., Engert, A., & Borchmann, S. (2018) · British Journal of Haematology · doi:10.1111/bjh.14705 · Cited by 27
Helminth-Induced IgE and Protection Against Allergic Disorders
Hamid, F., Amoah, A. S., van Ree, R., & Yazdanbakhsh, M. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-13725-4_5 · Cited by 28
Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
Tubin, S., Khan, M. K., Gupta, S., & Jeremic, B. M. (2021) · Cancers · doi:10.3390/cancers13040775 · Cited by 27
A role of eosinophils in mediating the anti-tumour effect of cryo-thermal treatment
Jia, S., Li, W., Liu, P., & Xu, L. X. (2019) · Scientific Reports · doi:10.1038/s41598-019-49734-5 · Cited by 26
Herrmann, T., Ginzac, A., Molnar, I., Bailly, S., Durando, X., & Mahammedi, H. (2021) · Cancer Medicine · doi:10.1002/cam4.4208 · Cited by 26
Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A. E., Luo, Y., Zhang, Y., & Knutson, K. L. (2019) · Immunotherapy · doi:10.2217/imt-2018-0128 · Cited by 25
Živančević-Simonović, S., Mihaljević, O., Majstorović, I., Djurdjevic, P. M., Kostić, I., Milošević-Djordjević, O., & Mijatović-Teodorović, L. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1619-7 · Cited by 25
Liu, W., Li, W., Ma, S., Liang, L., Kou, Z.-Y., & Yang, J. H. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101011 · Cited by 24
Deciphering the role of eosinophils in solid organ transplantation
Onyema, O. O., Guo, Y., Hata, A., Kreisel, D., Gelman, A. E., Jacobsen, E. A., & Krupnick, A. S. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15660 · Cited by 22
Advances in the Lung Cancer Immunotherapy Approaches
Padinharayil, H., Alappat, R. R., Joy, L. M., Anilkumar, K. V., Wilson, C. M., George, A., Gopalakrishnan, A. V., Madhyastha, H., Ramesh, T., Sathiyamoorthi, E., et al. (2022) · Vaccines · doi:10.3390/vaccines10111963 · Cited by 21
Palaia, I., Tomao, F., Pinto, A. D., Pernazza, A., Santangelo, G., D’Alessandris, N., Manganaro, L., ARNO, A., Donato, V. D., Perniola, G., et al. (2021) · In Vivo · doi:10.21873/invivo.12379 · Cited by 20
Takeuchi, E., Okano, Y., Machida, H., Atagi, K., Kondou, Y., Kadota, N., Hatakeyama, N., Naruse, K., & Shinohara, T. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02994-5 · Cited by 19
Takeuchi, E., Ogino, H., Kondo, K., Okano, Y., Ichihara, S., Kunishige, M., Kadota, N., Machida, H., Hatakeyama, N., Naruse, K., et al. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15191 · Cited by 19
Gambardella, A. R., Antonucci, C., Zanetti, C., Noto, F., Andreone, S., Vacca, D., Pellerito, V., Sicignano, C., Parrottino, G., Tirelli, V., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03129-1 · Cited by 19
Asthma status is associated with decreased risk of aggressive urothelial bladder cancer
Rava, M., Czachorowski, M. J., Silverman, D. T., Márquez, M., Kishore, S. A., Tardón, A., Serra, C., García‐Closas, M., García-Closas, R., Carrato, A., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31066 · Cited by 20
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab
Cazzola, M., Matera, M. G., Levi‐Schaffer, F., & Rogliani, P. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1446940 · Cited by 19
Li, Z., Luo, H., Li, C., Huo, X., Yan, C., Huang, X., Al‐Haddawi, M., Mathavan, S., & Gong, Z. (2014) · International Journal of Cancer · doi:10.1002/ijc.28794 · Cited by 19
Allergies: diseases closely related to cancer
Tirado-Rodríguez, B., & Huerta‐Yépez, S. (2016) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2016.11.006 · Cited by 19
Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors
Rogers, C. B. B., Zawislak, M. C., & Victoria Wong, P.-C. (2021) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2021.12.4.4 · Cited by 18
Ito, T., Hirahara, K., Onodera, A., Koyama‐Nasu, R., Yano, I., & Nakayama, T. (2017) · International Immunology · doi:10.1093/intimm/dxx051 · Cited by 16
Cao, L., Sun, P., He, Y., Yao, M., & Gao, H. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152751 · Cited by 16
Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma
Wang, G., Xu, S., Cao, C., Dong, J., Chu, Y., He, G., & Xu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.11545 · Cited by 16
Omero, F., Speranza, D., Murdaca, G., Cavaleri, M., Marafioti, M., Cianci, V., Berretta, M., Casciaro, M., Gangemi, S., & Santarpía, M. (2025) · Biomolecules · doi:10.3390/biom15040491 · Cited by 15
Ishida, Y., Kido, A., Akahane, M., Kishi, S., Tsukamoto, S., Fujii, H., Honoki, K., & Tanaka, Y. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.06.012 · Cited by 15
Wang, H., Wan, F., Gu, W., Zhu, Y., Dai, B., Shi, G., Zhang, H., & Ye, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12126 · Cited by 15
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma
Wu, X., Hou, P., Qiu, Y., Wang, Q., & Lu, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s257050 · Cited by 14
Sampaio-Ribeiro, G., Ruivo, A. D. S., Silva, A., Santos, A. L., Oliveira, R. C., Gama, J. M., Cipriano, M. A., Tralhão, J. G., & Paiva, A. A. (2023) · Cancers · doi:10.3390/cancers15123222 · Cited by 14
Rühle, P. F., Goerig, N. L., Wunderlich, R., Fietkau, R., Gaipl, U. S., Strnad, A. R., & Frey, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00296 · Cited by 14
Jo, S., Kim, T. J., Lee, H., Min, Y. W., Min, B., Lee, J. H., Son, H. J., Rhee, P., Baek, S., Kim, S. W., et al. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.71.1.38 · Cited by 14
Mascitti, M., Togni, L., Rubini, C., Troiano, G., Muzio, L. L., & Santarelli, A. (2021) · PubMed · doi:10.14670/hh-18-250 · Cited by 14
Singh, N., Lubana, S. S., Constantinou, G., & Leaf, A. N. (2020) · Case Reports in Oncological Medicine · doi:10.1155/2020/7492634 · Cited by 11
Eosinophils in metastatic melanoma
Proffer, S. L., Guo, R. R., Demer, A. M., & Peters, M. S. (2023) · Human Pathology · doi:10.1016/j.humpath.2023.08.001 · Cited by 11
Zhu, S., Zhou, Z., Gu, R., Zhao, Z., Zhang, Y., Miao, Y., Lei, Q., Liu, T., Wang, G., Dai, C., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00613-y · Cited by 9
Wylie, D., Wang, X., Yao, J. P., Xu, H., Ferrick-Kiddie, E. A., Iwase, T., Krishnamurthy, S., Ueno, N. T., & Lambowitz, A. M. (2026) · Science Advances · doi:10.1126/sciadv.adu0031 · Cited by 9
Galietta, V., Parisi, F., Cocumelli, C., Pierini, A., Poli, A., Scaramozzino, P., Spallucci, V., & Millanta, F. (2023) · Animals · doi:10.3390/ani13020283 · Cited by 9
Choudhary, N., Sarode, G. S., Yuwanati, M. B., Maniyar, N., Sarode, S. C., Gadbail, A. R., Gondivkar, S. M., & Patil, S. (2020) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2020.11.012 · Cited by 8
TSLP: contrasting roles in cancer
Poto, R., Marone, G., Ziegler, S. F., & Varricchi, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1627235 · Cited by 7
Bone marrow eosinophils in plasma cell disorders
Wichert, S., Pettersson, Å., Hellmark, T., Johansson, Å., & Hansson, M. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.288 · Cited by 7
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2016) · Nature Immunology · doi:10.1038/ni0216-214b · Cited by 7
The blood cells in NSCLC and the changes after RFA
Li, Y., Wang, D., & Li, X. (2020) · International Journal of Hyperthermia · doi:10.1080/02656736.2020.1782486 · Cited by 6
Yu, Q., Xie, T., Zhang, Y., Pan, T., Tan, Y., Qin, H., & Yan, S. (2023) · Environmental Toxicology · doi:10.1002/tox.24079 · Cited by 6
Identification of CISD1 as a Prognostic Biomarker for Breast Cancer
Liu, X., & Cui, Q. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s388537 · Cited by 5
Files, R., Okwu, V., Topa, N., Sousa, M., Silva, F. C., Rodrigues, P., Delgado, L., Prada, J., & Pires, I. C. R. (2024) · Animals · doi:10.3390/ani14030519 · Cited by 4
Chen, Y., Li, L.-Y., Li, J., He, R., Huang, Z., Huang, W.-Y., Luo, J., Dang, Y., Chen, G., & Wei, D. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2405879 · Cited by 4
Çim, N., Ayguler, E., Gunal, N., Çim, B., Atalmış, H. A., & Cetin, A. (2025) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_581_24 · Cited by 3
Assessment of Tissue Eosinophilic Infiltration in Invasive Mammary Carcinoma
Hasan, F., Fadhil, M. H., & Almukhtar, Z. K. S. (2024) · International Journal of Breast Cancer · doi:10.1155/2024/1514147 · Cited by 3
Allergies: diseases closely related to cancer
Tirado-Rodríguez, B., & Huerta‐Yépez, S. (2016) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.1016/j.bmhime.2017.11.042 · Cited by 3
Fujioka, H., Koike, T., Imamura, T., Kakeshita, K., Yamazaki, H., Abe, H., Nakajima, T., & Kinugawa, K. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02030-1 · Cited by 3
Hypereosinophilia-associated Diseases and the Therapeutic Agents in Development
Chung, I. Y. (2013) · Hanyang Medical Reviews · doi:10.7599/hmr.2013.33.1.65 · Cited by 2
Metadata
- Authors
- Gatault, S., Legrand, F., Delbeke, M., Loiseau, S., & Capron, M.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Corresponding author
- Gatault, Solène
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2012-06-17
- Volume
- 61
- Issue
- 9
- Pages
- 1527-1534
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11029779
- OpenAlex
- W2036123202
- Semantic Scholar
- 3afbb404c341e46dd8b82da492afaf7b19ae9c5e
- Cited by
- 132
- References
- 54
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 13 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 1
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- eosinophils, antitumor immunity, eosinophil recruitment, innate and adaptive immunity, hematologic malignancies, solid tumors, prognosis
- MeSH terms
- Animals, Eosinophils, Humans, Immunity, Innate, Neoplasms, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.